Kriya Therapeutics, Inc.

Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease.

Kriya is a biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world.

With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $900 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease and neurology.

For more information, please visit www.kriyatx.com and follow us on LinkedIn and X (Formerly Twitter).